ARTICLE | Company News
Pepscan Therapeutics, Phylogica deal
May 16, 2011 7:00 AM UTC
Pepscan will use its Chemical Linkage of Peptides onto Scaffolds (CLIPS) technology to optimize therapeutics from Phylogica against CD40 ligand ( CD40LG; CD40L; CD154) to treat rheumatoid arthritis ...